Co-Founder & Chief Strategy Advisor
Christopher Lee is a co-founder of Akita Biosciences. Chris is also a Co-Founder and Managing Partner at Despierta Ventures, a Miami-based health-tech venture fund, and venture studio.
Previously, Chris was Co-Founder and COO of InfiniteMD, a leading expert opinion technology company with 3,500 of the world’s top physicians with over 30M lives under management across Fortune 500 clients. InfiniteMD was acquired by ConsumerMedical in 2020 and ultimately Alight Solutions (NYSE:ALIT) in 2021. He served as SVP of Product and Innovation at ConsumerMedical. Chris also previously co-founded Recon Therapeutics, a TEDMED Hive inductee, representing one of the 20 most innovative healthcare startups globally.
Formerly the Director of MIT Hacking Medicine, Chris helped grow the community which has launched over 40+ active healthcare companies that have raised $200M+ in financing. Chris is an active angel investor, World Economic Forum Global Shaper, Forbes 30 Under 30, Medtech Boston 40 Under 40, and awarded MIT’s inaugural Broshy Fellowship.
Chris graduated summa cum laude with a BS in Biomedical Engineering from the University of Connecticut. He earned his masters from the Johns Hopkins Biodesign program in Bioengineering and doctorate in Medical Engineering with a focus on targeted drug delivery from the joint Harvard-MIT Division of Health Sciences and Technology program under the guidance of professors Michael Cima and Robert Langer. Chris has over a dozen publications spanning innovation, healthcare design thinking, and drug delivery.
Co-Founder and Chief Strategy Advisor
Christopher Lee is a co-founder of Akita Biosciences. Chris is also a Co-Founder and Managing Partner at Despierta Ventures, a Miami-based health-tech venture fund, and venture studio.
Previously, Chris was Co-Founder and COO of InfiniteMD, a leading expert opinion technology company with 3,500 of the world’s top physicians with over 30M lives under management across Fortune 500 clients. InfiniteMD was acquired by ConsumerMedical in 2020 and ultimately Alight Solutions (NYSE:ALIT) in 2021. He served as SVP of Product and Innovation at ConsumerMedical. Chris also previously co-founded Recon Therapeutics, a TEDMED Hive inductee, representing one of the 20 most innovative healthcare startups globally.
Formerly the Director of MIT Hacking Medicine, Chris helped grow the community which has launched over 40+ active healthcare companies that have raised $200M+ in financing. Chris is an active angel investor, World Economic Forum Global Shaper, Forbes 30 Under 30, Medtech Boston 40 Under 40, and awarded MIT’s inaugural Broshy Fellowship.
Chris graduated summa cum laude with a BS in Biomedical Engineering from the University of Connecticut. He earned his masters from the Johns Hopkins Biodesign program in Bioengineering and doctorate in Medical Engineering with a focus on targeted drug delivery from the joint Harvard-MIT Division of Health Sciences and Technology program under the guidance of professors Michael Cima and Robert Langer. Chris has over a dozen publications spanning innovation, healthcare design thinking, and drug delivery.
Join our subscribers lists to get the latest news and updates delivered directly to your inbox.
Join our subscribers lists to get the latest news and updates delivered directly to your inbox.